The succinct metaphor, 'the immune system's loaded gun', has been used to describe the role of mast cells (MCs) due to their storage of a wide range of potent pro-inflammatory and antimicrobial mediators in secretory granules that can be released almost instantly on demand to fight invaders. Located at host-environment boundaries and equipped with an arsenal of pattern recognition receptors, MCs are destined to be rapid innate sensors of pathogens penetrating endothelial and epithelial surfaces. Although the importance of MCs in antimicrobial and antiparasitic defense has long been appreciated, their role in raising the alarm against viral infections has been noted only recently. Work on cytomegalovirus (CMV) infection in the murine model has revealed MCs as players in a novel cross-talk axis between innate and adaptive immune surveillance of CMV, in that infection of MCs, which is associated with MC degranulation and release of the chemokine CCL5, enhances the recruitment of protective CD8 T cells to extravascular sites of virus replication, specifically to lung interstitium and alveolar epithelium. Here, we have expanded on these studies by investigating the conditions for MC activation and the consequent degranulation in response to host infection. Surprisingly, the data revealed two temporally and mechanistically distinct waves of MC activation: an almost instant indirect activation that depended on TLR3/TRIF signaling and delayed activation by direct infection of MCs that did not involve TLR3/TRIF signaling. Cell type-specific Cre-recombination that yielded eGFP-expressing reporter virus selectively originating from MCs identified MC as a new in vivo, first-hit target cell of productive murine CMV infection.
INTRODUCTION
Mast cells (MCs) are long-lived, tissue-resident cells of hematopoietic lineage origin that leave the bone marrow as committed MC progenitors and are recruited via the circulation to essentially all vascularized tissues where they mature. Mature MCs localize primarily to vessels and nerve endings and reside beneath endothelial and epithelial surfaces, where they perform their role as sentinels for environmental antigens and pathogens.
1,2 Upon activation, they deliver effector functions by releasing a host of pro-inflammatory and antimicrobial mediators, many of which are stored in granules that are prepared for instantaneous delivery upon degranulation, 3 a property that has led to the picture of MCs as being 'the immune system's loaded gun'. 4 MCs belong to the 'inbetweeners', cells of the immune system that combine properties of innate and adaptive immune cells and that have the potential to link classically innate and adaptive responses. The 'adaptive face' of MCs is their antigendependent activation through the canonical antigen receptor of the MCs, which is membrane-bound IgE antibody. Crosslinking of IgE on MCs triggers anaphylactic responses; therefore, MC function was long associated primarily with the pathophysiology of allergy, 5 although this is unlikely the physiological function of MCs. In searching for protective MC functions, mucosal MC activation through IgE was found to be involved in the expulsion of parasitic gastrointestinal helminths.
The 'innate face' of MCs 7 is based on the broad range of receptors that allow the stimulation of MCs independent of IgE. 8 The receptor repertoire includes numerous pattern recognition receptors (PRRs), which encompass most Toll-like receptors (TLRs), including TLR3 and TLR9. [9] [10] [11] In addition, MCs are reported to express complement receptors, G proteincoupled receptors, and CD48. This equipment enables MCs to recognize a wide array of exogenous ligands, pathogenassociated molecular patterns and endogenous ligands, all of which trigger danger signals in the host.
Linking innate to adaptive immunity, [12] [13] [14] MCs alerted through ligation of their PRRs can affect adaptive immunity by promoting the migration of antigen-laden, professional antigen-presenting cells to the draining lymph nodes, where they encounter antigen-specific T cells. To this end, MCs express and deliver molecules known to influence dendritic cell (DC)-and T-cell maturation and migration, including TNF, IL-1, MIP-1b, CCL5 (RANTES) and ligands for the costimulatory receptors CD40 and OX40. Specifically, activated MCs release chemokines, such as CCL5, to selectively recruit NK cells, NKT cells and T cells to non-lymphoid sites of immune surveillance. [15] [16] [17] [18] A large body of evidence indicates that release of vasoactive factors, including histamine, heparin, and TNF, by activated MCs can rapidly activate endothelial cells, 1 and this facilitate the extravasation of leukocytes, including T cells, to extravascular sites of infection, although increased vascular permeability can also contribute to MC-mediated immunopathology. 19 As a further link to adaptive immunity, infected MCs can directly serve as antigen-presenting cells by presenting peptides on MHC I and MHC II molecules, and uninfected MCs have been shown to be able to cross-present antigens. 20, 21 The contribution of MCs to antibacterial immunity has been well documented using strains of MC-deficient mice, 1 whereas in vivo evidence for a role of MCs in the control of viral infections is rather limited, but is an emerging topic. 16, 18, 22, 23 Cytomegaloviruses (CMVs) are strictly host species-specific dsDNA viruses of the beta-herpes virus subfamily that have cospeciated with their respective hosts, 24, 25 which precludes animal models for studying a role for MCs in human CMV infection. Medical interest in human CMV is based on severe organ manifestations of the disease it causes in congenitally infected neonates as well as in immunocompromised patients, particularly in recipients of allogeneic hematopoietic cell transplantation or solid organ allografts. 26, 27 Recent work in a murine model of interstitial CMV pneumonia that compared the infections of wild-type (WT) C57BL/6 mice and congenic MC-deficient Kit W-sh/W-sh mutants revealed a role for MC in enhancing the control of pulmonary infection by CCL5 chemokine-mediated recruitment of protective antiviral CD8 T cells to lung interstitium and alveolar epithelium. 18 Here, we expanded on these earlier studies by investigating the mode of in vivo MC activation by murine CMV (mCMV) in greater detail. Surprisingly, the data revealed two waves of MC activation and degranulation: a first wave indirectly depending on TLR3/TRIF signaling followed by a second wave associated with direct infection of MCs but not involving TLR3/TRIF signaling. 2/2 mice as described previously, 18 except that, to achieve accelerated MC reconstitution preferentially in the peritoneum, 3310 6 BMMC/500 ml PBS per mouse was transferred intraperitoneally, and MC degranulation experiments were performed 5 weeks later. 31 Measurement of in vivo virus-induced MC degranulation WT C57BL/6 mice, B6-congenic mice with gene knockouts affecting TLR3/TRIF or MyD88 signaling, and MC-reconstituted B6-congenic Kit W-sh/W-sh mice were infected intraperitoneally with 10 6 PFU/100 ml PBS of mouse embryo fibroblast cell culturepropagated, sucrose gradient-purified, bacterial artificial chromosome-derived viruses 32, 33 (i) mCMV MW97.01, 34 here, briefly referred to as mCMV; (ii) mutant virus mCMV-Dm157 lacking the ligand of the activating NK cell receptor Ly49H; 35 (iii) constitutive reporter virus mCMV-gfp; 36 and (iv) conditional reporter virus mCMV-Dm157-flox-egfp. 37 In one experiment, NK cells were depleted by intravenous administration of antibody directed against asialoGM1 (a-ASGM1, WAKO Chemicals, Neuss, Germany) 2 days before infection, as described previously. 38 At 4 h or 24 h post-infection, peritoneal exudate cells (PECs), including MCs, were recovered by peritoneal lavage. For infection with GFP/eGFP reporter viruses, cytofluorometric analysis of MC degranulation at 24 h was performed precisely as described recently. 18 In the 4-h degranulation assays performed after infection with WT mCMV or mCMV-Dm157 not expressing a fluorescent reporter protein, the PEC staining was modified. After nonspecific binding was blocked with unconjugated anti-FccRII/III, PECs were specifically stained with the following fluorochrome-conjugated antibodies (all from eBioscience, Frankfurt a.M., Germany): PE-conjugated anti-FceRI (clone MAR-1), PE-Cy7-conjugated anti-CD117 (clone ACK2) and Alexa Fluor 647-conjugated anti-CD107a (clone 1D4B). Analyses were performed with an LSRII flow cytometer and FACSDiva software V6.1.3 (BD Biosciences, San Jose, CA, USA).
MATERIALS AND METHODS

Quantitation of infectious, MC-derived reporter virus in host organs
After intraperitoneal infection of Mcpt5-cre mice with the conditional reporter virus mCMV-Dm157-flox-egfp, MC-derived, recombinant mCMV-Dm157-rec-egfp virus that had spread to host organs was quantitated in organ homogenates by counting green fluorescent foci in second-passage mouse embryo fibroblast monolayers infected with appropriate aliquots of organ homogenates (1/100 for the liver and 1/10 for lungs, spleen and salivary glands) under conditions of centrifugal enhancement of infectivity.
32,39
Statistical analysis Statistical tests were performed using GraphPad Prism version 6.04 for Windows (GraphPad Software, La Jolla, CA, USA). P values were calculated by unpaired two-tailed Student's t-test with Welch's correction, not assuming equal variance. Differences were considered significant if P,0.05.
RESULTS
CMV rapidly activates MCs in vivo
Any proposed implication of MCs in an antiviral immune response first demands the activation of MCs, be it by direct viral ligation of PRRs expressed on MCs or by indirect means, as a result of host infection involving cells other than MCs sending alarmins to MCs. To test for fulfillment of this prerequisite in the mCMV infection model of an immunocompetent host, peritoneal MCs recovered by peritoneal lavage following intraperitoneal mCMV infection were analyzed for activation. Importantly, a short-term (4-h) in vivo sensitization assay was used to restrict analysis to first-hit target cells before virus replication and secondary virus spread could occur. Activation of MCs was monitored by flow cytofluorometric analysis of CD107a on CD117
1 FceRI 1 MCs because CD107a (lysosomal-associated membrane protein-1) is exposed on the MC surface specifically upon degranulation. As shown qualitatively in Figure 1a and quantitatively in Figure 1b , infection is indeed associated with rapid degranulation of a significant proportion of MCs, which are known to release a broad range of highly biologically active mediators, including CCL5 that recruits CD8 T cells to organ sites of infection. 18 CMV sensitizes MCs for degranulation by inducing TLR3/ TRIF signaling Intraperitoneal application of poly(I : C), a synthetic ligand of PRR TLR3, has been reported to directly upregulate costimulatory molecules and the expression of cytokines and chemokines in MCs, resulting in chemotactic recruitment of CD8 T cells into the peritoneal cavity. 15 In a non-MC-related context, pathogen sensing through TLR3 has been reported for mCMV. 40 We therefore pursued the idea to link that information by testing if the CMV-triggered sensitization of MCs might possibly also be executed through the PRR TLR3 and adapter TRIF signaling pathway (Figure 1c ). Because TLRs other than TLR3 usually involve the MyD88 adapter signaling pathway, we compared MCdegranulation experiments with MyD88 2/2 and TRIF 2/2 mice to each other and to WT C57BL/6 mice as well as heterozygous MyD88 1/2 mice with the aim of first determining the signaling pathway involved in MC sensitization by mCMV. The results were unequivocal in showing that MC activation for degranulation is not impaired in the absence of MyD88, but is abandoned in the absence of TRIF. Additionally, we tested MC degranulation directly in TLR3 2/2 mice to exclude a role for any TRIF-dependent signaling involving alternative PRR other than TLR3. Notably, however, TLR3 2/2 proved to be as effective as TRIF 2/2 in preventing CMV-triggered degranulation of MCs.
In concert, these data revealed TLR3/TRIF signaling as one molecular mechanism by which mCMV can activate MCs. In principle, the manuscript could have ended here, as our question of how mCMV activates MCs appeared to be answered. What raised our concern was the previous finding that TLR3/ TRIF signaling in MCs can activate MCs to express costimulatory cell surface molecules and release cytokines and chemokines, but not stimulate degranulation. 15 This contradicts our first interpretation of the data, namely that they would provide evidence for mCMV inducing MC degranulation by directly stimulating the TLR3/TRIF signaling pathway in MCs.
TLR3 expression by MCs is dispensable for mCMV-mediated degranulation
To test whether direct TLR3 ligation on MCs is the key event for triggering degranulation following mCMV infection, we took advantage of MC-deficient mice reconstituted with MCs derived from WT or TLR3-deficient donors. Specifically, BMMCs from either WT C57BL/6 mice or TLR3 2/2 mutants were transferred intraperitoneally into Kit W-sh/W-sh 'sash' mutants lacking endogenous MC. 28, 29 Five weeks after reconstitution, the mice were infected with mCMV, and degranulation of MCs was monitored by CD107a expression in the 4-h in vivo sensitization assay (Figure 2a) . These data clearly demonstrate that MC activation for degranulation is independent of TLR3 expression by MCs (Figure 2b) . Thus, MC activation apparently depends on the ligation of TLR3 on additional cell type(s) very rapidly delivering MC-activating signals in response to mCMV, whereas activation of MCs in response to these signals does not require TLR3/TRIF signaling within the MCs.
Neither NK cells nor F4/80
1 macrophages are involved in the activation of MCs NK cells are among the first innate immune cells to sense mCMV infection and, besides exerting a direct effector function against infected cells, they secrete networking cytokines. 41, 42 This is particularly true in C57BL/6 mice, in which genetic host resistance to mCMV is based on the expression of the activating Ly49H receptor on NK cells, the ligand of which is the virally encoded protein m157. 43, 44 Hoping to discover an 'innateinbetweener-adaptive' immunoregulatory axis involving activation of NK cells by mCMV, activation of MC by NK cellderived cytokines and recruitment of CD8 T cells by activated MC, we tested for a putative role of NK cells in MC activation. However, as shown in Figure 3 , degranulation of MCs in the 4-h in vivo sensitization assay was absolutely unaffected by either depletion of pan-NK cells or infection with an mCMV mutant not expressing the Ly49H ligand m157 to specifically prevent viral activation of the Ly49H 1 subset of NK cells. 35 Likewise, peritoneal macrophages, which are frequent among PECs and known sites of mCMV infection, 45 were legitimate candidates for delivering the TLR3/TRIF-dependent signal. However, MC degranulation in the 4-h assay did not correlate with the proportion of macrophages and was not significantly influenced by macrophage depletion (Supplementary Figure 1) .
Direct infection of MCs triggers degranulation by a mechanism not dependent upon TLR3/TRIF signaling
As revealed in our recent work, 18 when using the GFP-expressing reporter virus mCMV-gfp, 36 infection of MCs is not discernible in a short-term (4-h) in vivo sensitization assay but becomes obvious in a long-term (24-h) in vivo sensitization assay, a time that still precludes a second round of infection and thus restricts the analysis to first-hit target cells. Notably, degranulation, measured by CD107a expression in CD117 1 FceRI 1 MCs, was found selectively in infected GFP 1 MCs. 18 Our first assumption was that degranulation measured in the 4-h assay actually also occurred in infected MCs triggered by the viral entry process combined with a TLR3/TRIF-dependent paracrine signal from other cells, although the level of GFP expression was not sufficiently high to identify these MCs as being infected. We therefore were confident that degranulation of infected GFP 1 MCs after the 24-h sensitization period would be absent in TLR3 2/2 and TRIF 2/2 mice, which are both deficient in TLR3/TRIF signaling. Surprisingly, however, the data left no doubt that degranulation of infected GFP 1 MCs does not require TLR3/ TRIF signaling, neither indirectly when providing a paracrine cofactor nor directly in the infected MCs (Figure 4 ).
Cell type-specific, conditional eGFP expression by selective Cre-recombination in MCs correlates the degranulation of MCs with the expression of recombined reporter virus In the experiment described above, infection of MCs was visualized using a reporter virus that constitutively expresses GFP under control of the human CMV promoter-enhancer. This proves viral entry into MCs and expression of the reporter gene. However, as cell types other than MCs also become infected and express the fluorescent reporter protein, this cannot provide evidence for completion of the viral replication cycle in MCs and release of infectious virions from MCs. To address this question, we employed cell type-specific Cre-mediated recombination of the floxed virus mCMV-Dm157-floxegfp, 37, 46 which selectively yielded the recombined eGFPexpressing reporter virus mCMV-Dm157-rec-egfp in MC of Mcpt5-cre transgenic mice expressing Cre-recombinase under control by the MC protease 5 promoter 30 (for the concept, see Figure 5a ).
Notably, a significant proportion of MCs expressed eGFP in the 24-h sensitization assay (Figure 5b ), and this level was actually comparable to the proportions observed before for mCMV-gfp constitutively expressing GFP (recall Figure 4) , which indicates a very good in vivo recombination efficacy in MCs of Mcpt5-cre mice. Importantly, again, MC degranulation was found to be restricted to infected GFP 1 MCs.
MC-specific Cre-recombination generates infectious reporter virus progeny
Because in this experimental system, the eGFP-expressing recombined virus mCMV-Dm157-rec-egfp can only originate from MCs, any detection of infectious progeny necessarily implies that MCs support the full viral replication cycle. To detect infectious viral progeny derived from MCs, we infected Mcpt5-cre mice intraperitoneally with mCMV-Dm157-floxegfp, allowed Cre-recombination and virus replication to occur untouched for a period of 48 h, and then immunocompromised the mice by 7 Gy of c-irradiation to facilitate virus spread from the peritoneal cavity to host organs (concept sketched in Figure 6a ). As mCMV infects many cell types, unrecombined virus was found to dominate in all organs, but in qualitative terms, the MC-derived, recombined mCMV-Dm157-rec-egfp virus was found to replicate in lungs and liver (Figure 6b) , and eGFP 1 fluorescent foci could be recovered upon infection of permissive cell monolayers with organ homogenates (Figure 6c ). These data prove that MCs support the full viral replication cycle and release infectious viral progeny. This finding also implies that, obviously, the event of degranulation of infected MCs does not prevent virus production by MCs.
DISCUSSION
Our results have revealed redundancy in the mechanisms by which mCMV infection activates MCs in vivo: a first wave of MC degranulation was already apparent after 4 h and critically involved TLR3/TRIF signaling, whereas delayed MC degranulation detected after 24 h was found to be restricted to infected (e)GFP 1 MCs and to be independent of TLR3/TRIF signaling. While an observation of degranulation at earlier and later times, as such, could also have indicated a continuous process lasting over the observation period, the different requirements for TLR3/TRIF signaling justify the discussion of two 'waves'. As MCs can be activated directly by ligation of TLR3 to upregulate costimulatory cell surface molecules and chemokines, but not degranulation, 15 it was unexpected to find that MCs derived from TLR3 2/2 mice and used to reconstitute MC-deficient TLR3 1/1 Kit W-sh/W-sh 'sash' mutants degranulate in response to host infection with mCMV. This finding excludes a critical involvement of TLR3/TRIF signaling within MCs in mCMV-associated MC degranulation. Instead, for the triggering event, we must propose a paracrine danger signal, an 'alarmin', which is delivered by another cell type immediately sensing mCMV infection in a TLR3/TRIF signaling-dependent manner. We have already excluded NK cells and F4/80 1 macrophages, known early innate sensors of mCMV-infected cells; therefore, the nature of this proposed cell type is still enigmatic. What we do know is that this cell must rapidly deliver a mediator in response to sensing mCMV in a TLR3/ TRIF-dependent manner. A time of 4 h for signaling, factor release and MC degranulation points to release of a stored factor on demand, rather than de novo synthesis, and excludes a wide array of alarmins that are known to depend on MyD88 signaling either for their production/release or for their action. Specifically, our finding of rapid MC degranulation in MyD88 2/2 mice excludes a role for IL-33, a member of the IL-1 family of cytokines and a noted alarmin that is released specifically by necrotic cells upon cell injury, resulting in MyD88-dependent MC activation, although again, not for degranulation. 47 In addition, 4 h of mCMV infection is by far too short of a time for viral necrosis of infected cells to occur. Similarly, MyD88 independence also excludes IL-12p70 from the candidate list. While IL-12p70 is critically involved in the early control of mCMV infection, prevention of TLR9/MyD88 signaling completely abolishes its serum release. 48 The promptness of the response and the signaling requirements also argue against a role for plasmacytoid DCs in secreting TNF-a. In their study on MyD88-dependent and MyD88-independent mCMV sensing, Delale and colleagues 48 noted two waves of IFN-a release, a first wave at 36 h that was MyD88-dependent and executed by plasmacytoid DCs and a second wave at 44 h that was MyD88-independent, plasmacytoid DC-independent and thought not to involve TLR sensing. First-hit target cells for mCMV infection via the intraperitoneal route include peritoneal macrophages and mesothelial cells lining the peritoneal cavity; 45 conspicuously, the latter also express a variety of TLRs, including TLR3. 49 In their pioneering, though in part not undisputed, 50 work on TLR sensing of mCMV, Tabeta and colleagues 40 noted that TLR9/MyD88 and TLR3/TRIF signaling are both involved in the innate immune defense against mCMV, as indicated by impaired control of virus replication in mice deficient in either of these signaling pathways. However, the cellular site of TLR3/ TRIF signaling was not identified in this early study, leaving us with mesothelial cells as promising candidates.
It remains an open question whether the 4 h-degranulation is restricted to MCs that have encountered mCMV virions or whether virus-untouched MCs also degranulate in response to the proposed TLR3/TRIF-dependent alarmin. In the GFP reporter assay, GFP expression did not discern a peak of GFP 1 MCs after 4 h; 18 however, this may reflect an insufficient amount of GFP present for detection and does not exclude a role for virion attachment and/or the viral entry process in the degranulation of MCs. We speculate that signals delivered by viral entry and TLR3/TRIF-dependent alarmin(s) are required to trigger this first wave of MC degranulation.
Overall, deciphering the signal(s) involved in the rapid MC degranulation in our experimental setting is a demanding, Sisyphus-type task because MCs can be activated by a variety of IgE-independent pro-inflammatory mediators. These include alarmins released upon cellular demise, reactive oxygen species generated under oxidative stress, anaphylatoxins, neuropeptides, endothelins and cationic antimicrobial peptides, to name a few. 8, 51 For the second wave of MC degranulation, the causality of direct infection of MCs became apparent from the very strict restriction of CD107a expression to GFP 1 or eGFP 1 MCs in constitutive or conditional reporter virus systems. Notably, a TLR3/TRIF-dependent cofactor was no longer needed. An obvious speculation is that a virally encoded protein that is not synthesized in sufficient amounts until later than 4 h after MC infection may replace the proposed TLR3/TRIF-dependent alarmin in co-signaling for degranulation. Recovery of the infectious reporter virus mCMV-Dm157-rec-egfp after cell type-specific, Cre-mediated recombination in MCs of Mcpt5-cre transgenic mice proved that MCs support the full viral replication cycle and that the triggering of degranulation does not interfere with this process.
It is tempting to ask if cells in the process of degranulation at 4 h might actually be the same as those detected after 24 h. In this regard, it is important to consider that, at any given time, one can only detect cells during and shortly after degranulation, so that the cumulative proportion of MCs degranulating within a longer period of time is likely higher than the proportion detected in our assays at defined times. Our data on CD107a (lysosomal-associated membrane protein-1) expression after ionomycin-triggered degranulation of BMMC in vitro indicate a turnaround time on the cell surface of 2-4 h (MS, unpublished data), which makes it unlikely that MCs degranulating at 4 h still express CD107a at 24 h. Furthermore, if CD107a expressed at 4 h would be maintained until 24 h, detection at 24 h should also have revealed a dependence on TLR3/ TRIF, which was not the case. MCs do not die after degranulation, but refill their pool of granules. Data indicate that human MC can recover for a second degranulation within 24 h. 52 Thus, we cannot exclude the possibility that MCs that have already degranulated in response to viral entry and a TLR3/TRIFdependent alarmin can degranulate again in an alarminindependent manner as the progression of viral gene expression has proceeded to a putative, virally encoded trigger of degranulation.
The question of which of the two 'waves' is biologically more relevant may be answered by our recent observation of elevated levels of the MC-derived chemokine CCL5 becoming detectable in serum not until day 2, 18 which suggests that the bulk of CCL5 is produced by successfully infected MCs during the second wave of MC degranulation. 
